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We hypothesized that left ventricular (LV) diastolic dysfunction assessed by cardiac catheterization may be associated with
increased risk for cardiovascular events. To test the hypothesis, we assessed diastolic function by cardiac catheterization (relaxation
timeconstant(Tau)andend-diastolicpressure(EDP))aswellasDopplerechocardiography(earlydiastolicmitralannularvelocity
(e ) and a ratio of early diastolic mitral inﬂow to annular velocities (E/e )) in 222 consecutive patients undergoing cardiac
catheterization for coronary artery disease (CAD). During a followup of 1364 ± 628 days, 5 cardiac deaths and 20 unscheduled
cardiovascular hospitalizations were observed. Among LV diastolic function indices, Tau > 48ms and e  < 5.8cm/swereeach
signiﬁcantly associated with lower rate of survival free of cardiovascular hospitalization. Even after adjustment for potential
confounders (traditional cardiovascular risk factors, the severity of CAD, and cardiovascular medications), the predictive value
of Tau > 48ms and e  < 5.8cm/s remained signiﬁcant. No predictive value was observed in EDP, E/e , or LV ejection fraction.
In conclusion, LV diastolic dysfunction, particularly impaired LV relaxation assessed by both cardiac catheterization and Doppler
echocardiography, is independently associated with increased risk for cardiac death or cardiovascular hospitalization in patients
with known or suspected CAD.
1.Introduction
Left ventricular (LV) diastolic dysfunction refers to abnor-
malities in relaxation, ﬁlling, and distensibility [1]. Evidence
of LV diastolic dysfunction can be determined by cardiac
catheterization [1]. The presence of LV diastolic dysfunction
can also be estimated by Doppler echocardiography [2, 3].
Although studies have shown that LV diastolic abnormalities
assessed by Doppler echocardiography are predictive of ad-
verse prognosis in various cardiac patients [4–10], the pre-
dictive value of invasively-determined diastolic dysfunction
is unclear. In the present study, we hypothesized that in-
vasively-determined diastolic dysfunction may be associated
with increased risk for cardiovascular events. To test the
hypothesis, we examined the association of LV diastolic
dysfunction assessed by cardiac catheterization as well as
Doppler echocardiography with subsequent cardiovascular
events in patients undergoing cardiac catheterization for
assessment of coronary artery disease (CAD).
2. Methods
2.1. Patients. We studied 222 consecutive Japanese patients
who underwent cardiac catheterization for the evaluation
of CAD between January 2004 and August 2006. All the
patients had symptoms suggestive of angina and/or clinical
signs of CAD (positive exercise electrocardiogram and/or
abnormal myocardial perfusion scintigram). No patients
withacutecoronarysyndrome,congestiveheartfailure,atrial
ﬁbrillation, primary valvular diseases, idiopathic dilated or2 Cardiology Research and Practice
hypertrophic cardiomyopathy, congenital heart disease, end-
stage renal disease on maintenance hemodialysis, or malig-
nant neoplasms were included. Medication status and a
history of coronary revascularization were determined by
review of medical records. Hypertension was deﬁned as
systolic blood pressure >140mmHg and/or diastolic blood
pressure >90mmHg measured by indirect arm-cuﬀ sphyg-
momanometry at rest or use of antihypertensive drugs. Dia-
betes wasdeﬁnedas afasting blood glucose level>126mg/dL
ortreatmentwithdietarymodiﬁcation,insulin,ororalhypo-
glycemic agents. Dyslipidemia was deﬁned as low-density li-
poprotein level ≥140mg/dL, high-density lipoprotein level
<40mg/dL, and/or triglyceride level ≥150mg/dL or treat-
ment with antihyperlipidemic agents. Within a week before
the index cardiac catheterization for this study, blood chem-
istry was obtained for assessment of clinical features. All the
patients gave written informed consents to participate in the
study, and this study was performed according to the regula-
tions proposed by the Ethical Guidelines Committee of the
NagoyaCityUniversityGraduateSchoolofMedicalSciences.
2.2. Cardiac Catheterization. Before contrast material was
injected into the LV or coronary artery, LV and aortic pres-
surewaveswereobtainedwithacatheter-tippedmicromano-
meter (SPC-454D, Millar Instrument Company, Houston,
TX)andrecordedonapolygraphsystem(RMC-2000,Nihon
Kohden, Inc., Tokyo, Japan) as previously reported [11].
Fromtherecordedpressurewaves,aorticsystolicanddiastol-
ic pressures and LV end-diastolic pressure (EDP) were deter-
mined. A time constant of decrease in LV pressure (Tau), an
index of early diastolic relaxation, was computed by applying
a monoexponential ﬁtting with zero asymptote to the LV
pressure decay [12]. LV end-systolic and end-diastolic vol-
umes were obtained from biplane left ventriculography by
useof the method proposed byChapman et al. [13]a n dw e r e
used for calculating ejection fraction (EF). The median val-
u e so fm e a s u r e m e n t so f3c o n s e c u t i v eb e a t sw e r eu s e df o r
statistical analyses.
2.3. Echocardiography. The day before the index cardiac
catheterization,ultrasoundexaminationwasperformedwith
the use of a commercially available echocardiographic ma-
chine (APLIO 80, Toshiba, Tokyo) with a 3-MHz transducer.
Patients were examined at rest in the left lateral decubitus
position. LV diastolic function was evaluated according to
the published guideline [14]. Transmitral ﬂow velocities
during early diastole (E) and atrial contraction (A) at the
mitral oriﬁce were obtained with the use of pulsed Doppler
echocardiographyintheapical4-chamberview.Deceleration
time was measured as the time from the peak early ﬁlling
velocity to termination of early ﬁlling. The peak early
diastolic annular velocity (e ) was measured with the use of
pulsed Doppler echocardiography at the septal and lateral
mitral annular sites. The values of e  measured at both sites
were averaged. The median values of measurements of 3
consecutive beats were used for statistical analyses. LV mass
was calculated from M-mode echocardiographic measure-
ments [15] and LV mass was corrected for body surface area.
2.4. Followup. Followup was determined in October 2010
with the use of the medical record and/or at regular visit
to determine the patients’ vital status and any cardiovascular
hospitalizations. The outcome of the present study was car-
diac death (acute myocardial infarction, heart failure, and
sudden cardiac death) or unscheduled admission for car-
diovascular causes. Sudden cardiac death was deﬁned as
unexpected death within one hour after the onset of a new
symptom, or unexpected, unobserved death.
2.5. Statistical Analysis. We used the SAS program package
(SAS Institute, Cary, NC) for statistical analyses. Diﬀerences
in quantitative and categorical data at baseline between
groups were compared by the Student’s t-test and the Fisher
exact probability test. The association between continuous
variables was determined by Pearson’s correlation analysis.
Survival curves of patients stratiﬁed by LV function indices
were calculated by the Kaplan-Meier method and compared
using the log-rank test. EDP of 16mmHg, Tau of 48ms, and
EF of 50% were used as cut-oﬀ points, because these values
are established thresholds for separating normal and abnor-
mallev els[1].Incontrast,reportedcut-oﬀpointsofechocar-
diographic diastolic measures (e  and E/e ) for the diagnosis
of diastolic dysfunction or the prediction of adverse progno-
sis are variable depending on age [2] and population studied
[4]. Furthermore, e  recorded at lateral mitral annular site is
usually higher than e  at septal site [4]. Thus, in the present
study, the best cut-oﬀ points of echocardiographic diastolic
measures were explored to maximize the likelihood ratio
in receiver-operating characteristic curves for the prediction
of the outcome. Hazard ratio of clinical variables for the
outcomewasdeterminedusingtheCoxproportionalhazards
regression analysis. To assess the independent predictive
value of LV function indices, the multivariate Cox hazards
regression analyses were performed including potential con-
founders based on the ﬁndings of previous studies and the
results of univariate analyses. Multivariate model 1 included
age, sex, hypertension, dyslipidemia, diabetes, and coronary
revascularization after the index cardiac catheterization.
Multivariate model 2 included previous history of myocar-
dial infarction, the number of coronary arteries narrowed,
EF, systolic aortic pressure, and heart rate. Multivariate
model3includeduseofcardiovascularmedications.Dataare
presented as the mean ± SD. Risk for death or cardiovascular
hospitalization is presented as hazard ratio (HR) with 95%
conﬁdenceinterval(CI).P<0.05wasconsideredsigniﬁcant.
3. Results
Based on the ﬁndings of the index coronary angiography,
50 percutaneous coronary interventions and 2 coronary
arterybypasssurgerieswereperformed.Duringafollowupof
1364 ± 628 (median (range), 1444 (16–2433)) days, 5 car-
diac deaths (4 heart failure and 1 sudden cardiac death) and
20 hospitalizations due to cardiovascular causes (15 ischemic
myocardial events (14 unstable angina and 1 acute myocar-
dial infarction), 3 heart failure, and 2 arrhythmia) were
observed. Clinical, hemodynamic, and echocardiographic
features of all patients and patient subgroups are shownCardiology Research and Practice 3
Table 1: Clinical, hemodynamic, and echocardiographic features of all patients and patient subgroups.
Variables All patients
(n = 222)
Outcomes∗,n o
(n = 197)
Outcomes, yes
(n = 25) P value†
Age, year 67 ±86 6 ±87 1 ±7 <0.01
Men 78% 79% 76% NS
Body mass index, kg/m2 24.1 ±3.22 4 .1 ±3.32 4 .3 ±2.8N S
Hypertension 49% 52% 29% <0.05
Diabetes 40% 39% 50% NS
Dyslipidemia 86% 84% 96% NS
Previous myocardial infarction 60% 59% 68% NS
Previous coronary revascularization 46% 45% 56% NS
Coronary revascularization after the index cardiac catheterization 23% 22% 32% NS
Serum creatinine, mg/dL 0.84 ±0.20 0.84 ±0.20 0.86 ±0.20 NS
Medications
Angiotensin converting enzyme inhibitors/angiotensin receptor
blockers 43% 45% 32% NS
β-blocker 41% 42% 38% NS
Calcium blocker 32% 34% 20% NS
Statin 58% 56% 79% <0.05
Antiplatelet agents 81% 80% 92% NS
Number of coronary arteries narrowed‡ NS
0 25% 26% 12%
1 26% 24% 40%
>1 49% 49% 48%
Heart rate, beat/min 68 ±12 68 ±12 65 ±12 NS
Systolic aortic pressure, mmHg 139 ±25 139 ±25 140 ±21 NS
Diastolic aortic pressure, mmHg 68 ±11 69 ±11 65 ±11 NS
Left ventricular end-diastolic pressure, mmHg 14.4 ±5.41 4 .3 ±5.21 5 .0 ±5.9N S
Relaxation time constant (Tau), ms 46.4 ±9.14 6 .0 ±9.14 9 .5 ±8.40 . 0 6
Left ventricular end-diastolic volume index, mL/m2 85.2 ±21.08 4 .5 ±21.49 0 .1 ±22.7N S
Left ventricular end-systolic volume index, mL/m2 34.0 ±19.23 3 .5 ±19.43 7 .6 ±18.0N S
Ejection fraction 62 ±13% 62 ±13% 60 ±11% NS
Echocardiographic indices
E/A 0.84 ±0.41 0.84 ±0.42 0.82 ±0.34 NS
Deceleration time, ms 211 ±50 213 ±51 200 ±45 NS
e  cm/s 7.0 ±2.07 .1 ±2.16 .4 ±1.70 . 0 6
E/e  9.6 ±3.39 .5 ±3.41 0 .0 ±2.8N S
Left ventricular mass index, g/m2¶ 108.6 ±27.6 107.2 ±26.9 121.6 ±30.90 . 0 5
Data are expressed as the mean ± standard deviation or frequency.
∗Outcomes were deﬁned as cardiac death (acute myocardial infarction, heart failure, and sudden cardiac death) or unscheduled admission for cardiovascular
causes.
†Outcomes yes versus no.
‡Narrowed coronary artery was deﬁned as major epicardial artery with ≥75% stenosis on angiogram.
¶Left ventricular mass was available in 152 patients.
in Table 1. Compared with patients who survived without
cardiovascular hospitalization during the followup, those
who died or were hospitalized due to cardiovascular causes
were more likely to be older, to be prescribed statins, and to
have higher levels of Tau and lower levels of e  and were less
likely to have hypertension.
Based on receiver-operating characteristic analyses for
the prediction of death or cardiovascular hospitalization,
the best cut-oﬀ points for e  and E/e  were determined as
5.8cm/s (sensitivity 56%, speciﬁcity 73%, likelihood ratio
2.06) and 13.2 (sensitivity 20%, speciﬁcity 88%, likelihood
ratio 1.69), respectively. Among LV function indices, sig-
niﬁcant univariate predictors for death or cardiovascular
hospitalization included Tau > 48ms (HR [95% CI] = 2.57
[1.13–5.81], P<0.05) and e  < 5.8cm/s (3.47 [1.57–7.70],
P<0.01). In contrast, no signiﬁcant predictive value was4 Cardiology Research and Practice
Table 2: Clinical and hemodynamic features of patient subgroups stratiﬁed by left ventricular relaxation time constant (Tau) and peak early
diastolic mitral annular velocity (e ).
Tau e 
≤48ms >48ms P Value
≥5.8cm/s <5.8cm/s P value
(n = 127) (n = 95) (n = 153) (n = 69)
Age, year 67 ±86 7 ±9N S6 5 ±87 0 ± 6 <0.001
Men 76% 82% NS 80% 75% NS
Body mass index, kg/m2 23.8 ±3.12 4 .5 ±3.3N S2 3 .9 ±3.32 4 .6 ± 3.0N S
Hypertension 47% 53% NS 52% 49% NS
Diabetes 40% 41% NS 35% 53% <0.05
Dyslipidemia 80% 94% <0.01 83% 91% NS
Previous myocardial infarction 48% 76% <0.001 53% 75% <0.01
Previous coronary revascularization 42% 53% NS 44% 52% NS
Coronary revascularization after the index
cardiac catheterization 18% 31% <0.05 19% 33% <0.05
Serum creatinine, mg/dL 0.83 ±0.19 0.85 ±0.21 NS 0.83 ±0.19 0.87 ±0.20 NS
Medications
Angiotensin converting enzyme
inhibitors/angiotensin receptor blockers 39% 48% NS 38% 55% <0.05
β-blocker 30% 56% <0.001 41% 41% NS
Calcium blocker 35% 29% NS 37% 23% <0.05
Statins 52% 66% NS 58% 60% NS
Antiplatelet agents 77% 87% <0.05 81% 82% NS
Number of coronary arteries narrowed <0.01 <0.01
0 32% 15% 31% 12%
1 26% 26% 26% 26%
>1 42% 59% 43% 62%
Heart rate, beat/min 71 ±12 64 ±10 <0.001 68 ±12 69 ±11 NS
Systolic aortic pressure, mmHg 142 ±27 134 ±21 <0.05 137 ±24 143 ± 27 0.07
Diastolic aortic pressure, mmHg 69 ±11 67 ±11 NS 68 ±10 68 ±12 NS
Left ventricular end-diastolic pressure,
mmHg 12.3 ±3.81 7 .2 ±5.7 <0.001 14.2 ±5.21 4 .8 ± 5.4N S
Relaxation time constant (Tau), ms 40.2 ±5.15 4 .6 ±6.1 <0.001 45.2 ±9.34 8 .9 ± 8.1 <0.01
Left ventricular end-diastolic volume index,
mL/m2 77.0 ±16.39 6 .1 ±23.1 <0.001 80.3 ±17.49 5 .9 ±25.8 <0.001
Left ventricular end-systolic volume index,
mL/m2 26.6 ±12.24 3 .9 ±22.3 <0.001 29.2 ±15.04 4 .5 ±23.1 <0.001
Ejection fraction, % 66 ±10 56 ±14 <0.001 65 ±12 56 ±14 <0.001
observed in EDP > 16mmHg (HR [95% CI] = 1.36 [0.61–
3.0], P = 0.4), EF < 50% (0.83 [0.29–2.4], P = 0.7), or E/e  >
13.2 (2.02 [0.76–5.42], P = 0.2). Survival curves of patients
stratiﬁed by Tau and e  are shown in Figure 1. Among other
variables listed in Table 1, signiﬁcant predictors for death or
cardiovascular hospitalization included age (HR [95% CI] =
2.21 [1.31–3.71] per 1-SD increment, P<0.01).
Clinical features of patients stratiﬁed by Tau and e  are
shown in Table 2. Compared with patients with Tau ≤ 48ms,
thosewithTau>48msweremorelikelytohavedyslipidemia
and history of myocardial infarction, to be prescribed β-
blockers,andtoundergocoronaryrevascularizationafterthe
index cardiac catheterization. Compared with patients with
e  ≥ 5.8cm/s, those with e  < 5.8c m / sw e r em o r el i k e l yt ob e
older, to have diabetes and history of myocardial infarction,
to be prescribed angiotensin converting enzyme inhibitors/
angiotensin receptor blockers, and to undergo coronary re-
vascularization after the index cardiac catheterization and
were less likely to be prescribed calcium blockers.
Hemodynamic and echocardiographic features of
patients stratiﬁed by Tau and e  are also shown in Tables
2 and 3. Compared with patients with Tau ≤ 48ms, those
with Tau > 48ms were more likely to have greater number of
coronary arteries narrowed and higher levels of heart rate,Cardiology Research and Practice 5
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Figure 1: Kaplan-Meier survival curves of patients stratiﬁed by left ventricular relaxation time constant (Tau) and early diastolic mitral
annular velocity (e ). CV indicates cardiovascular.
Table 3: Echocardiographic feature of patient subgroups stratiﬁed by left ventricular relaxation time constant (Tau) and peak early diastolic
mitral annular velocity (e ).
Tau e 
≤48ms >48ms P value
≥5.8cm/s <5.8cm/s P value
(n = 127) (n = 95) (n = 153) (n = 69)
Echocardiographic indices
E/A 0.79 ±0.23 0.90 ±0.55 0.05 0.87 ±0.33 0.77 ± 0.54 NS
Deceleration time, ms 218 ±48 201 ±52 NS 210 ±51 214 ±49 NS
e  cm/s 7.5 ±2.06 .4 ±1.9 <0.001 8.0 ±1.64 .8 ± 0.8 <0.001
E/e  8.8 ±2.81 0 .6 ±3.7 <0.001 8.3 ±2.31 2 .4 ±3.6 <0.001
Left ventricular mass index, g/m2 99.8 ±24.5 120.7 ±26.9 <0.001 101.5 ±25.4 122.9 ±26.5 <0.001
EDP, and LV volumes and lower levels of systolic aortic
pressure and EF. Compared with patients with e  ≥ 5.8cm/s,
those with e  < 5.8 c m / sw e r em o r el i k e l yt oh a v eg r e a t e r
number of coronary arteries narrowed and higher levels of
Tau, EDP, and LV volumes and lower levels of EF.
Patients who were diagnosed to have abnormal LV
relaxation by both cardiac catheterization and Doppler
echocardiography (Tau > 48ms and e  < 5.8cm/s(n = 41))
were more likely to be older, to have history of myocardial
infarction, to be higher in serum creatinine levels, LV vol-
ume, and LV mass index, and to be lower in EF, compared
with those who were diagnosed to have abnormal LV re-
laxation by only one modality (n = 82).
After adjustment for potential confounders (traditional
cardiovascular risk factors, the severity of CAD, and car-
diovascular medications, coronary revascularization after
the index cardiac catheterization), the predictive value of
Tau > 48ms continued to be signiﬁcant (Table 4). Similar
adjustment revealed the independent predictive value of e  <
5.8cm/s (Table 4).
Modest but signiﬁcant correlations were observed be-
tween LV diastolic function indices determined by cardiac
catheterization and those by Doppler echocardiography; Tau
correlated with e  (r =− 0.26, P<0.001) and E/e  (r = 0.26,
P<0.001) and EDP correlated with E/e  (r = 0.23, P<
0.001) but not with e  (r =− 0.08, P = 0.3).
4. Discussion
In the present study, we found that Tau > 48ms and e  <
5.8cm/s were each associated with an increased risk for car-
diac death or subsequent cardiovascular hospitalization in
patients undergoing cardiaccatheterizationforCAD.Incon-
trast, no prognostic value was observed in EDP, E/e ,o rE F .
Although studies have reported that LV diastolic abnor-
malitiesassessedbyDopplerechocardiographyarepredictive
of cardiac mortality and morbidity in patients with myocar-
dial infarction [5], those with heart failure with preserved
EF [7], those with reduced EF [8], and hypertensive subjects
[6, 9], only a few studies have examined the predictive value
of invasively-determined diastolic dysfunction. Speciﬁcally,
Liang et al. examined the prognostic value of EDP as well
as Doppler echocardiographic diastolic measures in patients
undergoing cardiac catheterization for CAD [16]. They6 Cardiology Research and Practice
Table 4: Unadjusted and adjusted hazard ratios of left ventricular relaxation time constant (Tau) > 48ms and peak early diastolic mitral
annular velocity (e ) < 5.8cm/s by Cox proportional hazards regression analysis.
Unadjusted Adjusted
Model 1∗ Model 2† Model 3‡
Tau > 48ms 2.57 (1.13–5.81)¶ 2.45 (1.04–5.82)¶ 3.12 (1.16–8.37)¶ 3.23 (1.31–7.97)¶
e  < 5.8cm/s 3.47 (1.57–7.70)# 2.38 (1.03–5.52)¶ 4.09 (1.75–9.57)# 3.81 (1.65–8.81)#
Data are represented as hazard ratio (95% CI).
∗Adjusted for age, sex, hypertension, dyslipidemia, diabetes, and coronary revascularization after the index cardiac catheterization.
†Adjusted for previous history of myocardial infarction, the number of coronary arteries narrowed, ejection fraction, systolic aortic pressure, andh e a r tr a t e .
‡Adjusted for use of β-blocker, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, calcium blocker, statin, and antiplatelet agents.
¶P<0.05.
#P<0.01.
found that EDP > 20mmHg and E/e  ≥ 15 were each
predictive of future heart failure events. In contrast, in our
study, no prognostic value was observed in EDP or E/e .
Compared with a cohort of Liang et al., our patients had
lower EDP (18.2 ± 7.3v e r s u s1 4 .4 ± 5.4mmHg) and E/e 
(12.5 ± 5.6v e r s u s9 .6 ± 3.3) levels, due probably to that
patients with congestive heart failure were not included in
ourstudy.Thus,EDPorE/e  maynotbepredictiveofadverse
prognosis in a cohort of patients without congestive heart
failure in which the majority have normal or slightly elevated
EDP and E/e .
The strength of the present study is that LV hemody-
namic variables were obtained with the use of a micro-
manometer catheter but not a ﬂuid-ﬁlled catheter. Although
a ﬂuid-ﬁlled catheter accurately measures late diastolic LV
pressures, it cannot precisely determine rapidly changing
pressures as occur during LV isovolumetric relaxation [17].
Use of a micromanometer catheter enabled us to determine
Tau,anindexofLVrelaxation.AlthoughLVrelaxationcanbe
estimated from e  on Doppler echocardiography, e  quanti-
tates the peak velocity of early diastolic longitudinal motion
of the mitral annulus [18] and measurement of e  only pro-
vides best-available noninvasive assessment of LV relaxation.
Our study is signiﬁcant in showing for the ﬁrst time the
prognostic value of abnormal LV relaxation determined by
cardiac catheterization in patients with known or suspected
CAD.
Although the present study does not provide direct
mechanisms underlying the association between abnormal
LV relaxation and adverse prognosis in patients with known
or suspected CAD, there are possible explanations. The most
common cause of cardiac death or cardiovascular hospital-
ization in our study was ischemic myocardial events. It is
well-established that the presence of myocardial ischemia
impairs LV relaxation [19]. In fact, we observed that patients
with impaired LV relaxation had more severe CAD (Table 2).
Thus, the prognostic association of impaired LV relaxation
may be mediated at least in part by CAD severity. We ob-
served,however,thatafteradjustmentfortheindex coronary
angiographic ﬁndings, the predictive value of impaired LV
relaxation remained signiﬁcant (Table 4, Model 2). Thus, a
part of the prognostic association of impaired LV relaxation
may be due to inducible myocardial ischemia regardless
of the stenoses of epicardial coronary arteries. Consistent
with this explanation, studies have shown that impaired LV
relaxation diminishes early diastolic coronary ﬂow [20, 21]
and may thereby further exaggerate myocardial ischemia
particularly when accompanied by tachycardia (such as
tachyarrhythmia and during exertion).
Another possible explanation for our observed associa-
tion of impaired LV relaxation with adverse prognosis is that
LV diastolic abnormalities may coexist with other disorders
that may adversely impact on prognosis. Speciﬁcally, Lee
et al. reported that altered LV diastolic function assessed
by Doppler echocardiography was independently associated
with endothelial dysfunction and hemostatic abnormalities
[22], both of which have been reported to be predictive
of the development of atherosclerotic diseases and ischemic
myocardial events in patients with CAD [23, 24].
There are several limitations in the present study. First,
LV mass was available in the limited number of the
patients(68%),whichcouldhaveinﬂuencedourresults[25].
Furthermore, estimation of LV mass by M-mode echocar-
diography in the presence of altered LV geometry such as
myocardial infarction may be inappropriate [15]. Second, we
did not measure left atrial volume index, a powerful pre-
dictor for left atrial pressure and clinical outcomes [14, 26].
Third, the time diﬀerence between cardiac catheterization
and Doppler echocardiographic examination is not small
(about one day). This may explain our observed modest cor-
relations of diastolic function indices obtained from cardiac
catheterization with those from Doppler echocardiography
and may also possibly explain the lack of prognostic value
of E/e . Forth, our study patients were composed of stable
known or suspected CAD patients without congestive heart
failure who were referred for cardiac catheterization for
assessment of CAD. Our ﬁndings cannot be extended to
other populations. Finally, our study is not large enough
to permit us to evaluate the association of LV diastolic
dysfunction with speciﬁc causes of death or hospitalization.
Our study suggests that measurement of e  by Doppler
echocardiography may provide useful information for risk
stratiﬁcation in known or suspected CAD patients without
congestive heart failure. The cut-oﬀ point of e  used in
the present study, however, is higher than that previously
reported. Speciﬁcally, Wang et al. reported that e  < 3cm/s
was a powerful predictor for cardiac death in patients with
reduced (<50%) EF [8]. Similarly, the same group reported
the predictive value of e  < 3.5cm/s for cardiac death in
hypertensive subjects with LV hypertrophy [9]. These resultsCardiology Research and Practice 7
suggest that the best cut-oﬀ point of e  for the prediction of
adverse prognosis may be variable depending on population
studied. Further studies are necessary for determining the
optimal cut-oﬀ points of e  for identifying high-risk patients
in various populations.
Our ﬁndings suggest that patients with impaired LV re-
laxation may need more aggressive treatment of CAD. A
recent study has reported that altered LV relaxation assessed
by Doppler echocardiography is improved after coronary re-
vascularization in patients with ischemic cardiomyopathy
[27]. The prognostic impact of improved LV relaxation after
coronary revascularization in CAD patients merits future
research.
References
[1] W. J. Paulus, C. Tsch¨ ope, J. E. Sanderson et al., “How to diag-
nose diastolic heart failure: a consensus statement on the diag-
nosisofheartfailurewithnormalleftventricularejectionfrac-
tion by the Heart Failure and Echocardiography Associations
of the European Society of Cardiology,” European Heart Jour-
nal, vol. 28, no. 20, pp. 2539–2550, 2007.
[2] M. J. Garcia, J. D. Thomas, and A. L. Klein, “New doppler
echocardiographic applications for the study of diastolic func-
tion,” Journal of the American College of Cardiology, vol. 32, no.
4, pp. 865–875, 1998.
[3] K. Yamamoto, Y. Sakata, T. Ohtani, Y. Takeda, and T. Mano,
“Heart failure with preserved ejection fraction,” Circulation
Journal, vol. 73, no. 3, pp. 404–410, 2009.
[4] C.M.Yu,J.E.Sanderson,T.H.Marwick,andJ.K.Oh,“Tissue
doppler imaging. A new prognosticator for cardiovascular
diseases,”Journal ofthe AmericanCollege of Cardiology, vol. 49,
no. 19, pp. 1903–1914, 2007.
[ 5 ]G .S .H i l l i s ,J .E .M ø l l e r ,P .A .P e l l i k k ae ta l . ,“ N o n i n v a s i v e
estimation of left ventricular ﬁlling pressure by E/e  is a pow-
erful predictor of survival after acute myocardial infarction,”
Journal of the American College of Cardiology,v o l .4 3 ,n o .3 ,p p .
360–367, 2004.
[6] A.S.P .Sharp ,R.J .T ap p ,S.A.M.Tho metal.,“T iss ueDo p ple r
E/E  ratio is a powerful predictor of primary cardiac events
in a hypertensive population: an ASCOT substudy,” European
Heart Journal, vol. 31, no. 6, pp. 747–752, 2010.
[7] H. Dokainish, W. A. Zoghbi, N. M. Lakkis et al., “Incremental
predictive power of B-type natriuretic peptide and tissue
Doppler echocardiography in the prognosis of patients with
congestive heart failure,” Journal of the American College of
Cardiology, vol. 45, no. 8, pp. 1223–1226, 2005.
[8] M. Wang, G. Yip, C. M. Yu et al., “Independent and incre-
mental prognostic value of early mitral annulus velocity in
patients with impaired left ventricular systolic function,” Jour-
nal of the American College of Cardiology, vol. 45, no. 2, pp.
272–277, 2005.
[9] M. Wang, G. W. K. Yip, A. Y. M. Wang et al., “Tissue Doppler
imaging provides incremental prognostic value in patients
with systemic hypertension and left ventricular hypertrophy,”
Journal of Hypertension, vol. 23, no. 1, pp. 183–191, 2005.
[10] H. Okura, T. Kubo, K. Asawa et al., “Elevated E/E  predicts
prognosis in congestive heart failure patients with preserved
systolic function,” Circulation Journal, vol. 73, no. 1, pp. 86–
91, 2009.
[11] H.Fukuta,N.Ohte,K.Wakamietal.,“Reducedrenalfunction
is associated with combined increases in ventricular-systolic
stiﬀness and arterial load in patients undergoing cardiac cath-
eterization for coronary artery disease,” Heart and Vessels, vol.
26, pp. 10–16, 2010.
[12] J. L. Weiss, J. W. Frederiksen, and M. L. Weisfeldt, “Hemody-
namic determinants of the time course of fall in canine left
ventricular pressure,” Journal of Clinical Investigation, vol. 58,
no. 3, pp. 751–760, 1976.
[13] C. B. Chapman, O. Baker, J. Reynolds, and F. J. Bonte, “Use of
biplane cineﬂuorography for measurement of ventricular vol-
ume,” Circulation, vol. 18, no. 6, pp. 1105–1117, 1958.
[14] S.F.Nagueh,C.P.Appleton,T.C.Gillebertetal.,“Recommen-
dations for the evaluation of left ventricular diastolic function
by echocardiography,” European Journal of Echocardiography,
vol. 10, no. 2, pp. 165–193, 2009.
[15] R. M. Lang, M. Bierig, R. B. Devereux et al., “Recommenda-
tions for chamber quantiﬁcation,” European Journal of Echo-
cardiography, vol. 7, no. 2, pp. 79–108, 2006.
[16] H. Y. Liang, S. A. Cauduro, P. A. Pellikka et al., “Comparison
of usefulness of echocardiographic Doppler variables to left
ventricular end-diastolic pressure in predicting future heart
failure events,” American Journal of Cardiology, vol. 97, no. 6,
pp. 866–871, 2006.
[17] W. C. Little and E. Braunwald, “Assessment of cardiac func-
tion,” in Heart disease: A Text Book of Cardiovascular Medicine,
Braunwald, Ed., pp. 421–444, W.B.Saunders, Philadelphia, Pa,
USA, 1997.
[18] S. F. Nagueh, K. J. Middleton, H. A. Kopelen, W. A. Zoghbi,
and M. A. Qui˜ nones, “Doppler tissue imaging: a noninvasive
technique for evaluation of left ventricular relaxation and esti-
mation of ﬁlling pressures,” Journal of the American College of
Cardiology, vol. 30, no. 6, pp. 1527–1533, 1997.
[19] W. Grossman and L. P. McLaurin, “Diastolic properties of the
left ventricle,” Annals of Internal Medicine,v o l .8 4 ,n o .3 ,p p .
316–326, 1976.
[20] L. J. Domalik-Wawrzynski, W. J. Powell, L. Guerrero, and I.
Palacios, “Eﬀect of changes in ventricular relaxation on early
diastolic coronary blood ﬂow in canine hearts,” Circulation
Research, vol. 61, no. 5, pp. 747–756, 1987.
[21] T. Masuyama, M. Uematsu, Y. Doi et al., “Abnormal coronary
ﬂow dynamics at rest and during tachycardia associated with
impaired left ventricular relaxation in humans: implication
for tachycardia-induced myocardial ischemia,” Journal of the
American College of Cardiology, vol. 24, no. 7, pp. 1625–1632,
1994.
[22] K. W. Lee, A. D. Blann, and G. Y. H. Lip, “Impaired tissue
Doppler diastolic function in patients with coronary artery
disease: relationship to endothelial damage/dysfunction and
platelet activation,” American Heart Journal, vol. 150, no. 4,
pp. 756–766, 2005.
[23] P. O. Bonetti, L. O. Lerman, and A. Lerman, “Endothelial
dys-function: a marker of atherosclerotic risk,” Arteriosclerosis,
Thrombosis, and Vascular Biology, vol. 23, no. 2, pp. 168–175,
2003.
[24] C. Held, P. Hjemdahl, N. H˚ akan Wall´ en et al., “Inﬂammatory
and hemostatic markers in relation to cardiovascular prog-
nosis in patients with stable angina pectorisResults from the
APSIS study,” Atherosclerosis, vol. 148, no. 1, pp. 179–188,
2000.
[25] J. K. Ghali, Y. Liao, B. Simmons, A. Castaner, G. Cao, and R. S.
Cooper, “The prognostic role of left ventricular hypertrophy
in patients with or without coronary artery disease,” Annals of
Internal Medicine, vol. 117, no. 10, pp. 831–836, 1992.8 Cardiology Research and Practice
[26] S. M. Stevens, R. Farzaneh-Far, B. Na, M. A. Whooley, and
N. B. Schiller, “Development of an Echocardiographic Risk-
Stratiﬁcation Index to Predict Heart Failure in Patients With
Stable Coronary Artery Disease. The Heart and Soul Study,”
JACC: Cardiovascular Imaging, vol. 2, no. 1, pp. 11–20, 2009.
[27] E. Carluccio, P. Biagioli, G. Alunni et al., “Eﬀect of revascular-
izing viable myocardium on left ventricular diastolic function
in patients with ischaemic cardiomyopathy,” European Heart
Journal, vol. 30, no. 12, pp. 1501–1509, 2009.